| __timestamp | Regeneron Pharmaceuticals, Inc. | Viatris Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 2614539000 | 3669400000 |
| Thursday, January 1, 2015 | 3711019000 | 4382200000 |
| Friday, January 1, 2016 | 4560733000 | 4998500000 |
| Sunday, January 1, 2017 | 5475166000 | 4976200000 |
| Monday, January 1, 2018 | 6276700000 | 4572000000 |
| Tuesday, January 1, 2019 | 7081200000 | 4444200000 |
| Wednesday, January 1, 2020 | 7377200000 | 3796700000 |
| Friday, January 1, 2021 | 13634200000 | 5575500000 |
| Saturday, January 1, 2022 | 10612500000 | 6497000000 |
| Sunday, January 1, 2023 | 11301400000 | 6438600000 |
| Monday, January 1, 2024 | 12231500000 |
Cracking the code
In the competitive landscape of pharmaceuticals, gross profit is a key indicator of a company's financial health and market prowess. Over the past decade, Regeneron Pharmaceuticals, Inc. has consistently outperformed Viatris Inc. in generating gross profit. From 2014 to 2023, Regeneron's gross profit surged by approximately 332%, peaking in 2021 with a remarkable 13.6 billion dollars. In contrast, Viatris experienced a more modest growth of around 76% during the same period, reaching its highest gross profit of 6.5 billion dollars in 2022.
This trend highlights Regeneron's robust growth strategy and market adaptability, especially evident in 2021 when its gross profit nearly doubled from the previous year. Meanwhile, Viatris, despite its steady growth, lags behind, emphasizing the competitive challenges it faces. As the pharmaceutical industry evolves, these financial insights provide a glimpse into the strategic maneuvers of these industry titans.
Gross Profit Trends Compared: Merck & Co., Inc. vs Viatris Inc.
Key Insights on Gross Profit: Gilead Sciences, Inc. vs Regeneron Pharmaceuticals, Inc.
Vertex Pharmaceuticals Incorporated vs Regeneron Pharmaceuticals, Inc.: A Gross Profit Performance Breakdown
Key Insights on Gross Profit: Regeneron Pharmaceuticals, Inc. vs Incyte Corporation
Regeneron Pharmaceuticals, Inc. and Jazz Pharmaceuticals plc: A Detailed Gross Profit Analysis
Regeneron Pharmaceuticals, Inc. vs Amneal Pharmaceuticals, Inc.: A Gross Profit Performance Breakdown
Who Generates Higher Gross Profit? Regeneron Pharmaceuticals, Inc. or Amphastar Pharmaceuticals, Inc.
Key Insights on Gross Profit: Regeneron Pharmaceuticals, Inc. vs Travere Therapeutics, Inc.
Gross Profit Trends Compared: Viatris Inc. vs Bio-Techne Corporation
Who Generates Higher Gross Profit? Viatris Inc. or BioMarin Pharmaceutical Inc.
Gross Profit Comparison: Viatris Inc. and Corcept Therapeutics Incorporated Trends
Who Generates Higher Gross Profit? Viatris Inc. or Veracyte, Inc.